No Detail Found!

Laryngeal mucormycosis in an uncontrolled diabetic patient: a case report

Author(s)
Erum Shahzadi Department of ENT, Ayub Medical College,Abbottabad-,Pakistan
Ali Shayan Department of ENT, Ayub Medical College,Abbottabad-,Pakistan
Zia-us-Salam Qazi Department of ENT, Ayub Medical College,Abbottabad-,Pakistan
Sarfraz Latif Department of ENT, Ayub Medical College,Abbottabad-,Pakistan
Sohail Ahmad Malik Department of ENT, Ayub Medical College,Abbottabad-,Pakistan
Usman Chaudhary Department of ENT, Ayub Medical College,Abbottabad-,Pakistan
Abstract
Background: With rising conditions in immunocompromised states, the world is facing the challenge of fungal infections with mucormycosis which was rare previously. With the rise in diabetic patients, COVID-19-related immunosuppression, and steroid use, along with an increasing number of transplant and chemotherapy patients, there has been a notable surge in mucorales infections. Although patients with rhino-orbit-cerebral mucormycosis are the most common type of pulmonary rare ones. Methods: Here, we are reporting 1st case of laryngeal mucormycosis in a 55-year-old male presented with respiratory distress in the ENT department of Shaikh Zayed Hospital, Lahore. He had a 4-year history of poorly controlled diabetes, with no other identifiable risk factors. An emergency tracheostomy was performed, pus was aspirated, and necrotic tissue was debrided to relieve the airway obstruction. Conclusion: Laryngeal mucormycosis was diagnosed in the subglottic region via multiple biopsies through direct laryngoscopy under anesthesia. The emergence of new variants of mucormycosis is calling for vigilant identification and meticulous control of predisposing risks. Concomitant debridement and intravenous amphotericin B are recommended under current guidelines.
Publication Details
Page(s) 678-680
Published Journal: Journal of Ayub Medical College, Volume: 36, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
COVID-19, Covid-19, Larynx, Mucormycosis
References
Prakash H,Chakrabarti A .2019 .Global epidemiology of Mucormycosis. , : .
. .. , : .
Skiada A,Lass-Floerl C,Klimko N,Ibrahim A,Roilides E,Petrikkos G. .2018 .Challenges in the diagnosis and treatment of mucormycosis. Med Mycol, 56 : S93-101.
. .. , : .
Singh AK,Singh R,Joshi SR,Misra A .2021 .Mucormycosis in COVID-19: a systematic review of cases reported worldwide. Diabetes Metab Syndr, 15 : .
.2021 .. , 05 : .
Ansari R,Dabirmoghaddam P,Lotfi M,Gheitani M,Sohrabpour S .2021 .Mucormycosis mimicking tracheal tumor: a case report. Iranian J Med Microbiol, 15 : 247-56.
Vandroux D,Allyn J,Ferdynus C,Gauzere BA,Kerambrun H,Galas T,Dis T .2019 .Mortality of critically ill patients with severe influenza started four years after the 2009 pandemic. , 51 : 831.
.2019 .. , 1668957 : .
Wolf O,Gil Z,Leider-Trejo L,Khafif A,Biderman P,Fliss DM .2004 .Tracheal mucormycosis presented as an intraluminal soft tissue mass. Head Neck, 26 : 541-3.
. .. , : .
Cornely OA,Arikan-Akdagli S,Dannaoui E,Groll AH,Lagrou K,Chakrabarti A .2014 .ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect, 20 : 5-26.
. .. , : 12371-0691.
He R,Hu C,Tang Y,Yang H,Cao L,Niu R . .Report of 12 cases with tracheobronchial mucormycosis and a review.. , : .
.2018 .. Clin Respir J, 12 : 1651.
. .. , : .
Yazicioglu Mocin O,Karakurt Z,Aksoy F,Gungor G,Partal M,Adiguzel N .2013 .Bronchoscopy as an indicator of tracheobronchial fungal infection in non-neutropenic intensive-care unit patients. Clin Microbiol Infect, 19 : E136.
. .. , : 12112-0691.
.2024 .. 2024 Revised: September, 26 : .
0

Citations

0

Downloads

36

Views